KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Other Operating Expenses (2016 - 2025)

Gilead Sciences' Other Operating Expenses history spans 17 years, with the latest figure at $2.6 billion for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 63.35% year-over-year to $2.6 billion; the TTM value through Dec 2025 reached $7.8 billion, down 48.01%, while the annual FY2025 figure was $7.8 billion, 48.01% down from the prior year.
  • Other Operating Expenses reached $2.6 billion in Q4 2025 per GILD's latest filing, up from $1.7 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $8.1 billion in Q1 2024 to a low of $1.3 billion in Q3 2021.
  • Average Other Operating Expenses over 5 years is $2.5 billion, with a median of $1.8 billion recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 331.31% in 2024, then plummeted 77.9% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $3.3 billion in 2021, then decreased by 3.88% to $3.2 billion in 2022, then decreased by 21.53% to $2.5 billion in 2023, then tumbled by 36.89% to $1.6 billion in 2024, then soared by 63.35% to $2.6 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Other Operating Expenses are $2.6 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.8 billion (Q2 2025).